Skip to main content
Erschienen in: Wiener klinische Wochenschrift 3-4/2013

01.02.2013 | Original Article

Clinical and laboratory features of viral hepatitis A in children

verfasst von: Zuzana Blechová, MD, Milan Trojánek, MD, Jan Kynčl, MD, PhD, Jitka Částková, MD, PhD, Jerry John, MD, Dr. Marek Malý, Kristýna Herrmannová, MD, Prof. Vilma Marešová

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2013

Einloggen, um Zugang zu erhalten

Summary

Recent outbreaks of viral hepatitis A in non-endemic European countries and the potential outbreak risk in susceptible populations has led us to evaluate the clinical characteristics of children hospitalised with hepatitis A. Retrospective study included 118 children (68 boys and 50 girls) with the mean age of 8.5 years hospitalised at Hospital Na Bulovce in Prague from June 2008 to June 2009. The clinical course was symptomatic icteric in 57 (48.3 %) children, symptomatic anicteric in 23 (19.5 %), subclinical in 22 (18.6 %) and asymptomatic inapparent in 16 (13.6 %). The relapse of the disease occurred in three patients. There were no cases of fulminant hepatitis. The most frequent symptoms included jaundice (57 cases), abdominal pain/discomfort (38), vomiting (38), dark urine (37), subfebrility (29) and fever (25). Hepatic injury markers were substantially elevated in icteric patients, but moderate elevations were identified in anicteric and subclinical cases as well. Lower white blood cell and lymphocyte counts were independently associated with symptomatic and more severe clinical course. Active immunisation was provided to 22 patients, and as a post-exposure prophylaxis to 19 of them. The clinical course and laboratory parameters in vaccinated children were not significantly different from non-vaccinated children. The clinical course of hepatitis A was largely self-limiting and benign. Asymptomatic infections are frequent, representing risk for disease spread; however, they are associated with elevations of hepatic injury markers. The inclusion of significant proportion of asymptomatic cases that were identified and investigated only because of active epidemiological surveillance in the outbreak focus represents the particular asset of this study.
Literatur
1.
Zurück zum Zitat Krugman S, Katz SL, editors. Infectious diseases of children. 7th ed. St Louis: Mosby; 1981. Krugman S, Katz SL, editors. Infectious diseases of children. 7th ed. St Louis: Mosby; 1981.
3.
Zurück zum Zitat Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006;28:101–11.PubMedCrossRef Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006;28:101–11.PubMedCrossRef
4.
Zurück zum Zitat Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18 Suppl 1:S71–4.PubMedCrossRef Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18 Suppl 1:S71–4.PubMedCrossRef
5.
Zurück zum Zitat Poovorawan Y, Theamboonlers A, Chongsrisawat V, Jantaradsamee P, Chutsirimongkol S, Tangkijvanich P. Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand. J Clin Virol. 2005;32(1):24–8.PubMedCrossRef Poovorawan Y, Theamboonlers A, Chongsrisawat V, Jantaradsamee P, Chutsirimongkol S, Tangkijvanich P. Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand. J Clin Virol. 2005;32(1):24–8.PubMedCrossRef
6.
Zurück zum Zitat Zimmerman HJ, Lowry CF, et al. Infectious hepatitis; clinical and laboratory features of 295 cases. Am J Med Sci. 1947;213(4):395–409.PubMedCrossRef Zimmerman HJ, Lowry CF, et al. Infectious hepatitis; clinical and laboratory features of 295 cases. Am J Med Sci. 1947;213(4):395–409.PubMedCrossRef
7.
Zurück zum Zitat Taylor RM, Davern T, Munoz S, et al. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology. 2006;44(6):1589–97.PubMedCrossRef Taylor RM, Davern T, Munoz S, et al. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology. 2006;44(6):1589–97.PubMedCrossRef
8.
Zurück zum Zitat Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology. 53(1):15–9.PubMedCrossRef Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology. 53(1):15–9.PubMedCrossRef
10.
Zurück zum Zitat Redlinger T, O’Rourke K, VanDerslice J. Hepatitis A among schoolchildren in a US-Mexico border community. Am J Public Health. 1997;87(10):1715–7.PubMedCrossRef Redlinger T, O’Rourke K, VanDerslice J. Hepatitis A among schoolchildren in a US-Mexico border community. Am J Public Health. 1997;87(10):1715–7.PubMedCrossRef
11.
Zurück zum Zitat Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine. 1992;10 Suppl 1:S18–20.CrossRef Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine. 1992;10 Suppl 1:S18–20.CrossRef
12.
Zurück zum Zitat Tosti ME, Spada E, Romano L, Zanetti A, Mele A. Acute hepatitis A in Italy: incidence, risk factors and preventive measures. J Viral Hepat. 2008;15 Suppl 2:26–32.PubMedCrossRef Tosti ME, Spada E, Romano L, Zanetti A, Mele A. Acute hepatitis A in Italy: incidence, risk factors and preventive measures. J Viral Hepat. 2008;15 Suppl 2:26–32.PubMedCrossRef
13.
Zurück zum Zitat Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004;132(6):1005–22.PubMedCrossRef Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004;132(6):1005–22.PubMedCrossRef
14.
Zurück zum Zitat Payne L, Coulombier D. Hepatitis A in the European Union: responding to challenges related to new epidemiological patterns. Euro Surveill. 2009;14(3):1–2. http://www.eurosurveillance.org/images/dynamic/EE/V14N03/art19101.pdf. Accessed 14 Jan 2012. Payne L, Coulombier D. Hepatitis A in the European Union: responding to challenges related to new epidemiological patterns. Euro Surveill. 2009;14(3):1–2. http://​www.​eurosurveillance​.​org/​images/​dynamic/​EE/​V14N03/​art19101.​pdf.​ Accessed 14 Jan 2012.
15.
Zurück zum Zitat European Centre for Disease Prevention and Control: annual epidemiological report on communicable diseases in Europe 2008. Report on the state of communicable diseases in the EU and EEA/EFTA countries. Stockholm: European Centre for Disease Prevention and Control; 2008. http://ecdc.europa.eu/en/publications/publications/0812_sur_annual_epidemiological_report_2008.pdf. Accessed 15 Jan 2012. European Centre for Disease Prevention and Control: annual epidemiological report on communicable diseases in Europe 2008. Report on the state of communicable diseases in the EU and EEA/EFTA countries. Stockholm: European Centre for Disease Prevention and Control; 2008. http://​ecdc.​europa.​eu/​en/​publications/​publications/​0812_​sur_​annual_​epidemiological_​report_​2008.​pdf.​ Accessed 15 Jan 2012.
17.
Zurück zum Zitat Castkova J, Benes C. Increase in hepatitis A cases in the Czech Republic in 2008—an update. Euro Surveill. 2009;14(3):1–3. http://www.eurosurveillance.org/images/dynamic/EE/V14N03/art19091.pdf. Accessed 10 Feb 2012. Castkova J, Benes C. Increase in hepatitis A cases in the Czech Republic in 2008—an update. Euro Surveill. 2009;14(3):1–3. http://​www.​eurosurveillance​.​org/​images/​dynamic/​EE/​V14N03/​art19091.​pdf.​ Accessed 10 Feb 2012.
18.
Zurück zum Zitat FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis A and E: update on prevention and epidemiology. Vaccine. 2010;28(3):583–8.PubMedCrossRef FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis A and E: update on prevention and epidemiology. Vaccine. 2010;28(3):583–8.PubMedCrossRef
19.
Zurück zum Zitat Vodak M, Helm R, Benda R. Protilatky proti viru hepatitidy A u zdravych osob [Antibodies against hepatitis A virus in the healthy population]. Cas Lek Cesk. 1981;120(6):152–4. Czech.PubMed Vodak M, Helm R, Benda R. Protilatky proti viru hepatitidy A u zdravych osob [Antibodies against hepatitis A virus in the healthy population]. Cas Lek Cesk. 1981;120(6):152–4. Czech.PubMed
20.
Zurück zum Zitat Nemecek V, Vennema H, Jagrova Z, Chalupa P, Smejkalova H, Benes C. Genotypova analyza izolatu viru hepatitidy A (HAV) z epidemiologickeho vyskytu 2008/2009 [Genotype analysis of viral hepatitis A isolates from outbreak in 2008/2009]. In: Dvorakova A. Proceedings of the 23rd Pecenka’s Days; 2009 Sep 22–24; Jihlava, Czech Republic: County Hygienic Station of Vysocina County in Jihlava; 2009. p. 43. http://www.pecenkovydny.cz/pdf/sbornik_PED_2009.pdf. Accessed 17 Feb 2012. Czech. Nemecek V, Vennema H, Jagrova Z, Chalupa P, Smejkalova H, Benes C. Genotypova analyza izolatu viru hepatitidy A (HAV) z epidemiologickeho vyskytu 2008/2009 [Genotype analysis of viral hepatitis A isolates from outbreak in 2008/2009]. In: Dvorakova A. Proceedings of the 23rd Pecenka’s Days; 2009 Sep 22–24; Jihlava, Czech Republic: County Hygienic Station of Vysocina County in Jihlava; 2009. p. 43. http://​www.​pecenkovydny.​cz/​pdf/​sbornik_​PED_​2009.​pdf.​ Accessed 17 Feb 2012. Czech.
21.
Zurück zum Zitat Bell BP, Shapiro CN, Alter MJ, Moyer LA, Judson FN, Mottram K, et al. The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies. J Infect Dis. 1998;178(6):1579–84.PubMedCrossRef Bell BP, Shapiro CN, Alter MJ, Moyer LA, Judson FN, Mottram K, et al. The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies. J Infect Dis. 1998;178(6):1579–84.PubMedCrossRef
22.
Zurück zum Zitat Ramonet M, Ciocca M, Haydee Nunez M, Afazani A, Arusa O, Planes N. Etiologia de la hepatitis viral aguda en una poblacion pediatrica. [Etiology of acute viral hepatitis in a pediatric population]. Medicina (B Aires). 1985;45(3):273–8. Spanish. Ramonet M, Ciocca M, Haydee Nunez M, Afazani A, Arusa O, Planes N. Etiologia de la hepatitis viral aguda en una poblacion pediatrica. [Etiology of acute viral hepatitis in a pediatric population]. Medicina (B Aires). 1985;45(3):273–8. Spanish.
23.
Zurück zum Zitat Sinlaparatsamee S, Nuniem J, Kankao J, Theamboonlers A, Chumdermpadetsuk S, Poovorawan Y. An outbreak of hepatitis A in school children at Nakhon Si Thammarat, southern Thailand. Southeast Asian J Trop Med Public Health. 1995;26(1):104–8.PubMed Sinlaparatsamee S, Nuniem J, Kankao J, Theamboonlers A, Chumdermpadetsuk S, Poovorawan Y. An outbreak of hepatitis A in school children at Nakhon Si Thammarat, southern Thailand. Southeast Asian J Trop Med Public Health. 1995;26(1):104–8.PubMed
24.
Zurück zum Zitat Staes CJ, Schlenker TL, Risk I, Cannon KG, Harris H, Pavia AT, et al. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics. 2000;106(4):E54.PubMedCrossRef Staes CJ, Schlenker TL, Risk I, Cannon KG, Harris H, Pavia AT, et al. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics. 2000;106(4):E54.PubMedCrossRef
25.
Zurück zum Zitat Jacobs WLW. Gamma-glutamyl-transpeptidase in diseases of the liver, cardiovascular system and diabetes mellitus. Clinica Chimica Acta. 1971;38:419–34.CrossRef Jacobs WLW. Gamma-glutamyl-transpeptidase in diseases of the liver, cardiovascular system and diabetes mellitus. Clinica Chimica Acta. 1971;38:419–34.CrossRef
26.
Zurück zum Zitat Wright R. Pathogenesis of viral hepatitis. Baillieres Clin Gastroenterol. 1990;4(3):695–705.PubMedCrossRef Wright R. Pathogenesis of viral hepatitis. Baillieres Clin Gastroenterol. 1990;4(3):695–705.PubMedCrossRef
27.
Zurück zum Zitat DeHoratius RJ, Strickland RG, Williams RC Jr. T and B lymphocytes in acute and chronic hepatitis. Clin Immunol Immunopathol. 1974;2(3):353–60.PubMedCrossRef DeHoratius RJ, Strickland RG, Williams RC Jr. T and B lymphocytes in acute and chronic hepatitis. Clin Immunol Immunopathol. 1974;2(3):353–60.PubMedCrossRef
28.
Zurück zum Zitat D’Argenio P, Adamo B, Cirrincione R, Gallo G. The role of vaccine in controlling hepatitis A epidemics. Vaccine. 2003;21(19–20):2246–9.PubMedCrossRef D’Argenio P, Adamo B, Cirrincione R, Gallo G. The role of vaccine in controlling hepatitis A epidemics. Vaccine. 2003;21(19–20):2246–9.PubMedCrossRef
29.
Zurück zum Zitat Kohl I, Nemecek V, Summerova M, Chlibek R, Nad’ova K, Minarikova O. Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks. Eur J Epidemiol. 2006;21(12):893–9.PubMedCrossRef Kohl I, Nemecek V, Summerova M, Chlibek R, Nad’ova K, Minarikova O. Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks. Eur J Epidemiol. 2006;21(12):893–9.PubMedCrossRef
30.
Zurück zum Zitat Hepatitis A: a vaccine at last. Lancet. 1992;339(8803):1198–9. Hepatitis A: a vaccine at last. Lancet. 1992;339(8803):1198–9.
Metadaten
Titel
Clinical and laboratory features of viral hepatitis A in children
verfasst von
Zuzana Blechová, MD
Milan Trojánek, MD
Jan Kynčl, MD, PhD
Jitka Částková, MD, PhD
Jerry John, MD
Dr. Marek Malý
Kristýna Herrmannová, MD
Prof. Vilma Marešová
Publikationsdatum
01.02.2013
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2013
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-012-0316-9

Weitere Artikel der Ausgabe 3-4/2013

Wiener klinische Wochenschrift 3-4/2013 Zur Ausgabe

mitteilungen der gesellschaft

ÖGIM FLIP